Switch to:
More From Other Websites
BioMarin Surging Beneath the Surface Nov 29 2016
Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $12.1 million of Shares Nov 23 2016
ETFs with exposure to BioMarin Pharmaceutical, Inc. : November 22, 2016 Nov 22 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Nov 21 2016
10 biotech companies ripe for a buyout, courtesy of Donald Trump Nov 17 2016
Soros 13F Points to More Than Just Emerging Markets Nov 15 2016
Why BioMarin (BMRN) Could Be Positioned for a Surge Nov 15 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bullish Manner : BMRN-US :... Nov 11 2016
Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $11.6 million of Shares Nov 09 2016
BioMarin Rises On 'Life-Changing' Hemophilia Drug, Trump Victory Nov 09 2016
Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty' Nov 09 2016
BIOMARIN PHARMACEUTICAL INC Financials Nov 09 2016
Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty' Nov 09 2016
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and... Nov 08 2016
Piper Jaffray Thinks It Might Be A Good Time For BioMarin To Sell Itself Nov 07 2016
BioMarin Pharm downgraded by Piper Jaffray Nov 07 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report Nov 03 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK